RecruitingNot ApplicableNCT07020546

Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score

Ovarian Platelet-Rich Plasma (oPRP) Injections Improvement In IVF Patients Based On Time-Lapse Incubator Culture for Automated Tracking and AI for Embryo Quality Assessment : A Non-Randomized Propsective Self-Controlled Interventional Study

Sponsor

Generation Next Fertility

Enrollment

180 participants

Start Date

Jul 8, 2025

Study Type

INTERVENTIONAL

Conditions

Poor ovarian reserve Infertility In-Vitro Fertilization Embryo Growth Disorder

Summary

Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 47 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Ovarian Platelet-rich plasma (PRP) injections for people with embryo growth disorder, in-vitro fertilization, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 47 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREOvarian Platelet-rich plasma (PRP) injections

This is a procedure that our patients receive at our clinic. We want to use the AI software to evaluate embryo development before and after treatment to see if there is a difference in embryo quality after PRP treatment within the same patient.